Intellectual Property

  • December 11, 2025

    Bradley Arant Adds Former Hilgers Graben Name Partner

    Bradley Arant Boult Cummings LLP has strengthened its litigation practice with a partner in Dallas who came aboard from Hilgers Graben PLLC, where he was a founder of that firm's Dallas shop.

  • December 10, 2025

    VLSI, PQA Square Off Again Over Conspiracy Claims In Va.

    A Virginia state judge spent two hours Wednesday working through whether VLSI Technology LLC should be able to proceed with its claims that Patent Quality Assurance LLC violated state law during its successful challenge to a VLSI chip patent.

  • December 10, 2025

    2nd Circ. Tosses Lego Rival's Appeal In IP Fight Over Figurine

    The Second Circuit on Wednesday dismissed a Lego rival's appeal challenging an order blocking the sale of its Third-Generation figurines, finding it lacked appellate jurisdiction since the district court correctly found the figurines fell within the ambit of an existing injunction due to a likelihood of confusion with Lego's Minifigure.

  • December 10, 2025

    Too Zealous? EscapeX Challenges Sanctions In Google Case

    EscapeX IP is asking the Federal Circuit to review en banc a decision upholding $255,000 in fees and sanctions for what a California federal judge found to be a frivolous patent suit against Google, arguing the decision contradicts precedent and raises questions for the whole legal profession.

  • December 10, 2025

    Judge Weighs Security Claims In Federal Bargaining Case

    A D.C. federal judge declined to immediately reinstate collective bargaining agreements for U.S. Patent and Trademark Office and National Weather Service employees Wednesday, saying the case brought by the workers was more "complicated" and "difficult" than other federal worker bargaining suits he'd recently enjoined.

  • December 10, 2025

    2nd Circ. Seems Iffy On Salvation For 'Made In Heaven' IP Row

    A Second Circuit panel seemed skeptical Wednesday of an Italian prop and set designer's challenge to a lower court's dismissal of his infringement case against artist Jeff Koons over his "Made in Heaven" series, as the judges appeared to doubt arguments that he didn't bring the suit too late.

  • December 10, 2025

    Teva Pulls 200 Patents From Orange Book Amid FTC Probe

    The Federal Trade Commission said Wednesday an investigation it conducted into Teva Pharmaceuticals prompted the company to remove over 200 patents from the U.S. Food and Drug Administration's Orange Book.

  • December 10, 2025

    Syngenta, Corteva Face Class Cert. Bids For $2B In Damages

    Pesticide companies Syngenta and Corteva are facing damages claims of more than $1.2 billion and $883 million claim, respectively, according to class certification bids filed by farmers looking to represent the hundreds of thousands of pesticide buyers allegedly harmed by rebate programs that paid distributors to forgo cheaper generics.

  • December 10, 2025

    Apple Tells Fed. Circ. ITC Move Boosts Watch Case Appeal

    Apple Inc. has told the Federal Circuit that the U.S. International Trade Commission's decision last month to review whether a redesigned Apple Watch infringes Masimo Corp. patents "underscores the need" for the appeals court to reverse the ITC's original infringement finding.

  • December 10, 2025

    3rd Circ. Locks In 'Made In USA' False Ad Ruling

    The Third Circuit on Wednesday upheld a $2.1 million disgorgement award to a Maryland caulking-gun manufacturer that accused a New Jersey competitor of falsely advertising its products as American-made when they were imported from Taiwan, in violation of the Lanham Act and state law.

  • December 10, 2025

    VPR Settles Trademark Dispute With Chinese Vape Makers

    The three-year legal saga between U.S. and Chinese vaping companies over who could control the Elf Bar name appears to be coming to an end, the parties have told a Florida federal court, saying they've reached a deal that would end a number of overlapping intellectual property lawsuits that made it all the way to the Federal Circuit.

  • December 10, 2025

    Skyworks Fights Challenge To USPTO Policies At Fed. Circ.

    Skyworks Solutions is pushing the Federal Circuit to ignore a Chinese company's challenge to new U.S. Patent and Trademark Office policies on when patent reviews can be denied, saying the dispute should be tossed the same as other similar challenges.

  • December 10, 2025

    LeBron Secures 'More Than An Athlete' TM Win At Fed. Circ.

    The Federal Circuit on Wednesday shot down a challenge to the Trademark Trial and Appeal Board's finding that NBA star LeBron James and his company Uninterrupted IP LLC have the trademark rights to the phrase "More Than An Athlete."

  • December 10, 2025

    Meta Hit With Patent Claims Over Ray-Ban Smart Glasses

    Meta is facing a lawsuit by a smart appliance company that claims Meta's Orion artificial intelligence-powered smart glasses and its Ray-Ban smart glasses are infringing a patent.

  • December 09, 2025

    USPTO Assignor Estoppel Denials Flout Law, Fed. Circ. Told

    Cloud database company Tessell Inc. has told the Federal Circuit that the U.S. Patent and Trademark Office is violating the court's clear precedent by refusing to review patents when the challengers include the named inventors.

  • December 09, 2025

    German Software Co. Settles Suit Over Ex-HP-Owned Patents

    German software company SAP SE has inked a deal to end a lawsuit in Texas federal court accusing it of infringing various patents owned by Valtrus Innovations Ltd. covering computer data and communication.

  • December 09, 2025

    Kiss' Gene Simmons Sings Praises Of Radio Pay Bill

    U.S. lawmakers are revisiting an effort to get FM and AM radio broadcasters to pay artists when playing their music, with key members of a Senate subcommittee speaking at a hearing Tuesday in favor of a measure that also garnered enthusiastic support from Kiss singer Gene Simmons.

  • December 09, 2025

    CoStar Urges Justices To Review Revived Antitrust Claims

    CoStar is asking the U.S. Supreme Court to review a Ninth Circuit ruling reviving antitrust counterclaims from a rival commercial real estate platform, saying the appeals court accepted a novel theory of what constitutes exclusive dealing.

  • December 09, 2025

    Generic-Drug Group Backs House Bill On Skinny Labels

    An industry group representing the generic and biosimilar drug manufacturing sector has applauded the introduction of a U.S. House of Representatives bill titled The Skinny Labels, Big Savings Act, saying it will reduce prices across healthcare.

  • December 09, 2025

    Fed. Circ. OKs PTAB's Axing Of Some IBM Patent Claims

    The Federal Circuit on Tuesday affirmed a Patent Trial and Appeal Board decision that invalidated some claims while preserving others in an IBM patent covering a single sign-on technology, rejecting the company's arguments that the board relied on arguments not made by the patent challenger.

  • December 09, 2025

    Ed Sheeran Can Challenge Copyright On 'Let's Get It On'

    A Manhattan federal judge said Tuesday that she would allow Ed Sheeran to challenge the validity of a 2020 copyright on elements of the Marvin Gaye track "Let's Get It On" before the copyright holder is permitted to amend its suit alleging Sheeran's hit song "Thinking Out Loud" infringes it.

  • December 09, 2025

    Comcast Can't Get Fed. Circ. To Move Patent Case To Pa.

    The Federal Circuit on Tuesday shot down Comcast's bid to overturn an Eastern District of Texas judge's decision declining to transfer an infringement suit the telecom behemoth is facing in his court to the Eastern District of Pennsylvania.

  • December 09, 2025

    Cooley Adds 30-Person Life Sciences IP Team From Dechert

    A trio of Dechert LLP partners, including the co-chair of its global intellectual property practice, have joined Cooley LLP alongside a team of special counsel, associates and patent agents, the firm announced Tuesday.

  • December 09, 2025

    Marsh Rival Wants Out Of Employee Poaching Scheme Suit

    An insurance company accused by Marsh & McLennan Agency of poaching an employee has asked a Manhattan federal judge to dismiss Marsh's suit, saying the court had no jurisdiction because the claims had not been sufficiently tied to New York.

  • December 09, 2025

    NFL's Lions Want Suit Over Goff Photos Out Of California

    The Detroit Lions are looking to snuff out a photographer's copyright case in California federal court over the team's use of photos he took of quarterback Jared Goff, raising doubts about the dispute's ties to the Golden State.

Expert Analysis

  • FTC, CoStar Cases Against Zillow May Have Broad Impact

    Author Photo

    Zillow's partnerships with Redfin and Realtor.com have recently triggered dual fronts of legal scrutiny — an antitrust inquiry from the Federal Trade Commission and a mass copyright infringement suit from CoStar — raising complex questions that reach beyond real estate, says Shubha Ghosh at Syracuse University College of Law.

  • Parenting Skills That Can Help Lawyers Thrive Professionally

    Author Photo

    As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.

  • Enablement Standard Insights From Fed. Circ. Agilent Ruling

    Author Photo

    The Federal Circuit's recent enablement standard decision in Agilent v. Synthego underscores three critical takeaways for patent practitioners, including reaffirmation that the enablement inquiry under Section 102 of the Patent Act is distinct from the inquiry under Section 112, say attorneys at MoFo.

  • How WTO's Anti-Suit Injunction Ruling Affects IP Stakeholders

    Author Photo

    The World Trade Organization's recent ruling in favor of the European Union's challenge to Chinese courts' anti-suit injunction practices should hearten holders of standard-essential patents, while implementers can take solace that they retain mechanisms to distinguish the WTO decision when seeking anti-suit injunctions in U.S. courts, says Michael Franzinger at Dentons.

  • Series

    Teaching Trial Advocacy Makes Us Better Lawyers

    Author Photo

    Teaching trial advocacy skills to other lawyers makes us better litigators because it makes us question our default methods, connect to young attorneys with new perspectives and focus on the needs of the real people at the heart of every trial, say Reuben Guttman, Veronica Finkelstein and Joleen Youngers.

  • Why Civil RICO Claims Are Gaining Traction With Plaintiffs

    Author Photo

    A Texas federal court's recent $71 million verdict in Point Bridge Capital v. Johnson demonstrates that, when used properly, civil lawsuits under the Racketeering Influenced and Corrupt Organizations Act can be a devastating weapon — and increasingly favorable for plaintiffs, says Akiva Shapiro at Gibson Dunn.

  • You're Out?: Rooftop Views Of Sports Games Raise IP Issues

    Author Photo

    A high-profile dispute between the Chicago Cubs and a rooftop business adjacent to Wrigley Field strikes at the intersection of sports, intellectual property and Chicago neighborhood tradition, highlighting novel questions that could significantly affect IP rights in the context of live events generally, say attorneys at Troutman Pepper.

  • 5 Key Steps To Prepare For Oral Arguments

    Author Photo

    Whether presenting oral arguments before the U.S. Supreme Court or a local county judge, effective preparation includes the same essential ingredients, from organizing arguments in blocks to maximizing the potential of mock exercises, says Allison Rocker at Baker McKenzie.

  • A Change In Big Pharma Response To FTC Delisting Warnings

    Author Photo

    While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent listings in the U.S. Food and Drug Administration's Orange Book had been de minimis through the end of last year, July data shows an increase in delistings, say Ratib Ali and Celia Lu at Competition Dynamics.

  • 9th Circ. Finding That NFTs Are Goods Will Change TM Law

    Author Photo

    The Ninth Circuit's recent ruling in Yuga Labs v. Ripps establishes that NFTs have real, commercial value under U.S. federal trademark law, a new legal precedent that may significantly influence intellectual property enforcement and marketplace policies regarding digital assets going forward, say attorneys at Wilson Elser.

  • Series

    Adapting To Private Practice: From Texas AUSA To BigLaw

    Author Photo

    As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.

  • Data Undermines USPTO's 'Settled Expectations' Doctrine

    Author Photo

    An analysis of inter partes review proceedings filed since 2012 appears to refute the U.S. Patent and Trademark Office's recent stance that patent owners develop a strong settled expectation that their patents will not be challenged after being in force for six years, say Jonathan DeFosse and Samuel Smith at Sheppard Mullin, and Kenzo Kasai at NGB Corp.

  • Advice For 1st-Gen Lawyers Entering The Legal Profession

    Author Photo

    Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.

  • Fed. Circ. In July: Instability In IPR Requirements

    Author Photo

    The Federal Circuit's decision in Shockwave v. Cardiovascular last month provided an important, albeit short-lived, clarification to the type of evidence that can be used in an inter partes review challenge, say attorneys at Knobbe Martens.

  • Structuring Noncompetes In License And Collaboration Deals

    Author Photo

    As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.